Actively Recruiting
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
Led by Shanghai Huaota Biopharmaceutical Co., Ltd. · Updated on 2025-02-14
33
Participants Needed
3
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a Phase IIb, long term extension study to evaluate the safety and efficacy of HB0034 in adult subjects with generalized pustular psoriasis (GPP).
CONDITIONS
Official Title
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients participated in the preceding placebo-controlled Phase 2 study (HB0034-04) and completed at least the Week 12 visit of that study
- Subject must be a candidate for prolonged GPP treatment according to the Investigator's judgment
- Men and women of reproductive age who have no parenting plans and are willing to use reliable contraception during the study period and for 6 months after the last dose of the study drug
- Patients who fully understand and voluntarily sign an informed consent form, and are willing and able to follow clinical study and subsequent visit schedules
You will not qualify if you...
- Patients who are experiencing a generalized pustular psoriasis flare
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Peking University People's Hospital (PKUPH)
Beijing, China
Actively Recruiting
2
Peking University People's Hospital
Beijing, China
Actively Recruiting
3
The Second affiliated Hospital zhejiang University School of Medicine
Hangzhou, China
Actively Recruiting
Research Team
G
Guodong Zhou
CONTACT
Q
Qiaoxia Qian, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here